Amgen announced today the launch of AMJEVITA (adalimumab-atto), a biosimilar to AbbVie’s HUMIRA (adalimumab), in the United States. AMJEVITA was the first HUMIRA biosimilar approved by...
Related Keywords
United States , , Amgen , European Union , Wholesale Acquisition Cost ,
comparemela.com © 2020. All Rights Reserved.